文献速递临床试验与 GCP真实世界研究与卫生经济

针对创伤患者的早期职业康复与心理支持以改善重返工作(ROWTATE 试验):一项个体随机对照多中心实用性试验的研究方案

Early vocational rehabilitation and psychological support for trauma patients to improve return to work (the ROWTATE trial): study protocol for an individually randomised controlled multicentre pragmatic trial.
PubMed 文献 · Trials · 2024-07-02

ROWTATE 是一项在英格兰八家重大创伤中心开展的个体随机对照多中心实用性试验,计划纳入 722 例损伤严重度评分(ISS)>8 的创伤患者,1:1 随机接受早期职业康复与心理支持(按需)加常规照护或单纯常规照护。主要目标为评估干预能否在随机化后 12 个月时使患者自报重返工作/教育达到伤前工时的至少 80% 方面优于单纯常规照护。

要点

  • 纳入标准为 ISS>8 的中重度或重大创伤患者,入组时间为入院后 12 周内。
  • 干预由职业治疗师提供,必要时由临床心理学家提供,个体化定制,最长持续 12 个月。
  • 主要结局为随机化后 12 个月时自报重返工作/教育达到伤前工时的至少 80%。

核心结论

  • 该试验将提供关于重大创伤人群职业康复干预的有力证据。
  • 临床与经济有效的职业康复干预证据对委托方和提供方在 NHS 内采纳职业康复服务具有重要意义。

研究设计与样本

  • 个体随机对照多中心实用性试验,包含内部预试验、经济评估、过程评估和实施研究。
  • 计划在英格兰八家重大创伤中心招募 722 例 ISS>8 的参与者,按 1:1 随机分配至职业康复与心理支持(按需,经心理筛查后)加常规照护组或单纯常规照护组。

主要发现

  • 干预在招募后 2 周内由职业治疗师提供,必要时由临床心理学家提供,个体化定制,根据参与者需求持续不超过 12 个月。
  • 基线评估收集人口学、损伤详情、工作/教育状态、认知障碍、焦虑、抑郁、创伤后痛苦、残疾、恢复期望、经济压力和健康相关生活质量等数据。
  • 在随机化后 3、6、12 个月通过邮寄/电话/在线问卷进行随访。
  • 主要结局为随机化后 12 个月时自报重返工作/教育达到伤前工时的至少 80%。
  • 次要结局包括其他工作结局(如工作/教育小时数、重返工作/教育时间、病假缺勤)、抑郁、焦虑、创伤后痛苦、工作自我效能、经济压力、生活目标、健康相关生活质量和医疗/个人资源使用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Moderately severe or major trauma (injury severity score (ISS) > 8) is common, often resulting in physical and psychological problems and leading to difficulties in returning to work. Vocational rehabilitation (VR) can improve return to work/education in some injuries (e.g. traumatic brain and spinal cord injury), but evidence is lacking for other moderately severe or major trauma. METHODS: ROWTATE is an individually randomised controlled multicentre pragmatic trial of early VR and psychological support in trauma patients. It includes an internal pilot, economic evaluation, a process evaluation and an implementation study. Participants will be screened for eligibility and recruited within 12 weeks of admission to eight major trauma centres in England. A total of 722 participants with ISS > 8 will be randomised 1:1 to VR and psychological support (where needed, following psychological screening) plus usual care or to usual care alone. The ROWTATE VR intervention will be provided within 2 weeks of study recruitment by occupational therapists and where needed, by clinical psychologists. It will be individually tailored and provided for ≤ 12 months, dependent on participant need. Baseline assessment will collect data on demographics, injury details, work/education status, cognitive impairment, anxiety, depression, post-traumatic distress, disability, recovery expectations, financial stress and health-related quality of life. Participants will be followed up by postal/telephone/online questionnaires at 3, 6 and 12 months post-randomisation. The primary objective is to establish whether the ROWTATE VR intervention plus usual care is more effective than usual care alone for improving participants' self-reported return to work/education for at least 80% of pre-injury hours at 12 months post-randomisation. Secondary outcomes include other work outcomes (e.g. hours of work/education, time to return to work/education, sickness absence), depression, anxiety, post-traumatic distress, work self-efficacy, financial stress, purpose in life, health-related quality of life and healthcare/personal resource use. The process evaluation and implementation study will be described elsewhere. DISCUSSION: This trial will provide robust evidence regarding a VR intervention for a major trauma population. Evidence of a clinically and cost-effective VR intervention will be important for commissioners and providers to enable adoption of VR services for this large and important group of patients within the NHS. TRIAL REGISTRATION: ISRCTN: 43115471. Registered 27/07/2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kendrick D, Lindley R, Blackburn L, et al. Early vocational rehabilitation and psychological support for trauma patients to improve return to work (the ROWTATE trial): study protocol for an individually randomised controlled multicentre pragmatic trial. Trials. 2024. PMID: 38956682. doi:10.1186/s13063-024-08183-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。